Shareholders Will Probably Hold Off On Increasing Otonomy, Inc.'s (NASDAQ:OTIC) CEO Compensation For The Time Being

Shareholders of Otonomy, Inc. (NASDAQ:OTIC) will have been dismayed by the negative share price return over the last three years. What is concerning is that despite positive EPS growth, the share price has not tracked the trend in fundamentals. These are some of the concerns that shareholders may want to bring up at the next AGM held on 22 June 2021. They could also influence management through voting on resolutions such as executive remuneration. We think shareholders might be reluctant to increase compensation for the CEO at the moment, according to our analysis below.

See our latest analysis for Otonomy

Advertisement

Comparing Otonomy, Inc.'s CEO Compensation With the industry

At the time of writing, our data shows that Otonomy, Inc. has a market capitalization of US$134m, and reported total annual CEO compensation of US$2.9m for the year to December 2020. Notably, that's an increase of 33% over the year before. We think total compensation is more important but our data shows that the CEO salary is lower, at US$568k.

On comparing similar-sized companies in the industry with market capitalizations below US$200m, we found that the median total CEO compensation was US$727k. Hence, we can conclude that David Weber is remunerated higher than the industry median. What's more, David Weber holds US$115k worth of shares in the company in their own name.

Component20202019Proportion (2020)
SalaryUS$568kUS$546k20%
OtherUS$2.3mUS$1.6m80%
Total CompensationUS$2.9m US$2.2m100%

Talking in terms of the industry, salary represented approximately 28% of total compensation out of all the companies we analyzed, while other remuneration made up 72% of the pie. Otonomy pays a modest slice of remuneration through salary, as compared to the broader industry. If total compensation is slanted towards non-salary benefits, it indicates that CEO pay is linked to company performance.

ceo-compensation
NasdaqGS:OTIC CEO Compensation June 16th 2021

Otonomy, Inc.'s Growth

Otonomy, Inc.'s earnings per share (EPS) grew 24% per year over the last three years. Its revenue is down 64% over the previous year.

Shareholders would be glad to know that the company has improved itself over the last few years. It's always a tough situation when revenues are not growing, but ultimately profits are more important. Moving away from current form for a second, it could be important to check this free visual depiction of what analysts expect for the future.

Has Otonomy, Inc. Been A Good Investment?

Few Otonomy, Inc. shareholders would feel satisfied with the return of -46% over three years. This suggests it would be unwise for the company to pay the CEO too generously.

To Conclude...

Shareholders have not seen their shares grow in value, rather they have seen their shares decline. The fact that the stock price hasn't grown along with earnings may indicate that other issues may be affecting that stock. If there are some unknown variables that are influencing the stock's price, surely shareholders would have some concerns. At the upcoming AGM, shareholders will get the opportunity to discuss any issues with the board, including those related to CEO remuneration and assess if the board's plan will likely improve performance in the future.

It is always advisable to analyse CEO pay, along with performing a thorough analysis of the company's key performance areas. In our study, we found 4 warning signs for Otonomy you should be aware of, and 3 of them are significant.

Of course, you might find a fantastic investment by looking at a different set of stocks. So take a peek at this free list of interesting companies.

If you’re looking to trade Otonomy, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted


New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

About OTCPK:OTIC

Otonomy

Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States.

Mediocre balance sheet and slightly overvalued.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2533.3% undervalued
157 users have followed this narrative
0 users have commented on this narrative
26 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
35 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.527.2% undervalued
18 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.723.9% undervalued
47 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

RO
RockeTeller
SSV logo
RockeTeller on Southern Silver Exploration ·

302 Million Oz Silver Project in Mexico: Low Cost Underground Giant Ready to Explode

Fair Value:CA$32.198.0% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
J_
J_Tyrader
OSCR logo
J_Tyrader on Oscar Health ·

7/8/26 — Oscar Health: Trading 95.4% below Fair Value with +2070.2% Upside Potential

Fair Value:US$583.3495.2% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
andre_santos
PG logo
andre_santos on Procter & Gamble ·

Procter & Gamble - A Fundamental Valuation

Fair Value:US$107.5235.6% overvalued
26 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28020.0% undervalued
273 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.1% overvalued
141 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0942.2% undervalued
166 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative